Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Four Stocks Registering Big Gains on Friday?

Page 1 of 2

With the stock market in the green on Friday on the back of a cut in interest rates in China and a boost in the tech sector on the back of earnings (the NASDAQ is up by almost 2%), several companies are standing above the crowd in beating the broader market. Namely Gigamon Inc (NYSE:GIMO), Celyad SA (ADR) (NASDAQ:CYAD)Quality Systems, Inc. (NASDAQ:QSII), and athenahealth, Inc (NASDAQ:ATHN) have registered significant jumps on the back of varied news. Let’s take a closer look at what has sparked the hype around these four companies.

10 best industries to invest in

Gigamon Inc (NYSE:GIMO) has advanced by over 20% so far on the back of its financial results for the third quarter. The company posted a 44% annual growth in revenue to $56.7 million and an adjusted net income of $0.22 per share, up from $0.04 delivered a year earlier. Gigamon Inc (NYSE:GIMO) also managed to beat the EPS estimates by around $0.05. Among the funds from our database, Gigamon Inc (NYSE:GIMO) is not very popular, with only 24 funds reporting long stakes as of the end of June, however, they amassed around 18% of its outstanding stock at the time, which suggests an overall bullish sentiment. Among them, Thomas Ellis and Todd Hammer’s North Run Capital and Israel Englander‘s Millennium Management held the largest positions, containing 1.45 million shares and 862,746 shares respectively.

We think that the smart money sentiment is an important metric in assessing the long-term profitability on a stock, because hedge funds usually conduct due diligence in their investment process, since they operate with large amounts of capital. Even though collectively, hedge funds have been underperforming the benchmarks for the last couple of months, they had strong returns on the long side of their portfolios. For example, the 15 most popular small-cap picks among the more than 700 hedge funds from our database have outperformed the S&P 500 ETF (SPY) by some 53 percentage points, returning 102% since August 2012 (see more details here).

Celyad SA (ADR) (NASDAQ:CYAD) has also climbed by over 17% after the announcement that the U.S Patent Office had issued a patent related to allogeneic human primary T-Cells engineered to be T-Cell Receptor-deficient and express a Chimeric Antigen Receptor. Celyad SA (ADR) (NASDAQ:CYAD) went public on the NASDAQ in June and has yet to capture the attention of large investors, since only six funds from our database reported stakes equal to 3.80% of its outstanding stock as of the end of June. Despite today’s gains, Celyad SA (ADR) (NASDAQ:CYAD)’s stock is down by 29% since its IPO.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!